表紙
市場調査レポート

中国における心調律管理装置市場の見通し

China Cardiac Rhythm Management Market Outlook to 2020

発行 GlobalData 商品コード 303996
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
中国における心調律管理装置市場の見通し China Cardiac Rhythm Management Market Outlook to 2020
出版日: 2014年05月16日 ページ情報: 英文 58 Pages
概要

当レポートでは、中国における心調律管理装置市場について、心臓再同期療法用装置(除細動器およびペースメーカー)、埋込型心臓除細動器、埋込型心電図記録計、ペースメーカーのカテゴリー別売上、販売数の実績および予測、平均価格、企業シェア、流通シェア、主要企業のプロファイル、パイプライン製品、主な財務取引についての最新情報などを提供しまとめており、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

  • レポートの内容
  • 心調律管理装置市場の区分
  • 本レポートで対象としている市場の定義

第3章 中国における心調律管理装置

  • 収益(実績)
  • 収益(予測)
  • 販売数(実績)
  • 販売数(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 主要企業の概要

  • Medtronic, Inc.
  • Boston Scientific Corporation
  • St.Jude Medical, Inc.
  • Biotronik SE & Co. KG
  • Sorin S.p.A.
  • 日本光電

第5章 パイプライン製品

第6章 財務取引の情勢

  • 提携

第7章 付録

図表

目次
Product Code: GDMECC0392DB

GlobalData's new report, "China Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the China Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Cardiac Rhythm Management Devices categories - Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.
  • Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
  • 2012 company shares and distribution shares data for the market category.
  • Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Cardiac Rhythm Management Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Cardiac Rhythm Management Market, China

  • 3.1. Cardiac Rhythm Management Market, China, Revenue ($m), 2005-2012
  • 3.2. Cardiac Rhythm Management Market, China, Revenue ($m), 2012-2020
    • 3.2.1. Cardiac Resynchronisation Therapy Market, China, Revenue ($m), by Segment, 2005-2012
    • 3.2.2. Implantable Cardioverter Defibrillators Market, China, Revenue ($m), by Segment, 2005-2012
    • 3.2.3. Pacemakers Market, China, Revenue ($m), by Segment, 2005-2012
    • 3.2.4. Cardiac Resynchronisation Therapy Market, China, Revenue ($m), by Segment, 2012-2020
    • 3.2.5. Implantable Cardioverter Defibrillators Market, China, Revenue ($m), by Segment, 2012-2020
    • 3.2.6. Pacemakers Market, China, Revenue ($m), by Segment, 2012-2020
  • 3.3. Cardiac Rhythm Management Market, China, Volume (Units), 2005-2012
  • 3.4. Cardiac Rhythm Management Market, China, Volume (Units), 2012-2020
    • 3.4.1. Cardiac Resynchronisation Therapy Market, China, Volume (Units), by Segment, 2005-2012
    • 3.4.2. Implantable Cardioverter Defibrillators Market, China, Volume (Units), by Segment, 2005-2012
    • 3.4.3. Pacemakers Market, China, Volume (Units), by Segment, 2005-2012
    • 3.4.4. Cardiac Resynchronisation Therapy Market, China, Volume (Units), by Segment, 2012-2020
    • 3.4.5. Implantable Cardioverter Defibrillators Market, China, Volume (Units), by Segment, 2012-2020
    • 3.4.6. Pacemakers Market, China, Volume (Units), by Segment, 2012-2020
  • 3.5. Cardiac Rhythm Management Market, China, Average Price ($), 2005-2020
  • 3.6. Cardiac Rhythm Management Market, China, Distribution Share by Revenue ($m), 2011-2012
  • 3.7. Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), 2011-2012

4. Overview of Key Companies in China, Cardiac Rhythm Management Market

  • 4.1. Medtronic, Inc.
    • 4.1.1. Company Overview
  • 4.2. Boston Scientific Corporation
    • 4.2.1. Company Overview
  • 4.3. St. Jude Medical, Inc.
    • 4.3.1. Company Overview
  • 4.4. Biotronik SE & Co. KG
    • 4.4.1. Company Overview
  • 4.5. Sorin S.p.A.
    • 4.5.1. Company Overview
  • 4.6. Nihon Kohden Corporation
    • 4.6.1. Company Overview

5. Cardiac Rhythm Management Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. MicroPort Scientific To Form Joint Venture With Sorin

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Market Modeling and Forecasting
    • 7.1.5. Company Share Analysis
    • 7.1.6. Distribution Share Analysis
  • 7.2. Expert Panel
  • 7.3. GlobalData Consulting
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 2: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 3: Cardiac Resynchronisation Therapy Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 4: Implantable Cardioverter Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 5: Pacemakers Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Table 6: Cardiac Resynchronisation Therapy Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 7: Implantable Cardioverter Defibrillators Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 8: Pacemakers Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Table 9: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012
  • Table 10: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020
  • Table 11: Cardiac Resynchronisation Therapy Market, China, Volume (Units), Historic, 2005-2012
  • Table 12: Implantable Cardioverter Defibrillators Market, China, Volume (Units), Historic, 2005-2012
  • Table 13: Pacemakers Market, China, Volume (Units), Historic, 2005-2012
  • Table 14: Cardiac Resynchronisation Therapy Market, China, Volume (Units), Forecast, 2012-2020
  • Table 15: Implantable Cardioverter Defibrillators Market, China, Volume (Units), Forecast, 2012-2020
  • Table 16: Pacemakers Market, China, Volume (Units), Forecast, 2012-2020
  • Table 17: Cardiac Rhythm Management Market, China, Average Price ($), Historic, 2005-2012
  • Table 18: Cardiac Rhythm Management Market, China, Average Price ($), Forecast, 2012-2020
  • Table 19: Cardiac Rhythm Management Market, China, Distribution Share by Revenue ($m), USD Constant, 2011-2012
  • Table 20: Cardiac Rhythm Management Market, China, Company Share by Revenue ($m), USD Constant, 2011-2012
  • Table 21: Cardiac Rhythm Management Market Pipeline Products
  • Table 22: MicroPort Scientific To Form Joint Venture With Sorin
  • Table 23: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 2: Cardiac Rhythm Management Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 3: Cardiac Resynchronisation Therapy Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 4: Implantable Cardioverter Defibrillators Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 5: Pacemakers Market, China, Revenue ($m), USD Constant, Historic, 2005-2012
  • Figure 6: Cardiac Resynchronisation Therapy Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 7: Implantable Cardioverter Defibrillators Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 8: Pacemakers Market, China, Revenue ($m), USD Constant, Forecast, 2012-2020
  • Figure 9: Cardiac Rhythm Management Market, China, Volume (Units), Historic, 2005-2012
  • Figure 10: Cardiac Rhythm Management Market, China, Volume (Units), Forecast, 2012-2020
  • Figure 11: Cardiac Resynchronisation Therapy Market, China, Volume (Units), Historic, 2005-2012
  • Figure 12: Implantable Cardioverter Defibrillators Market, China, Volume (Units), Historic, 2005-2012
  • Figure 13: Pacemakers Market, China, Volume (Units), Historic, 2005-2012
  • Figure 14: Cardiac Resynchronisation Therapy Market, China, Volume (Units), Forecast, 2012-2020
  • Figure 15: Implantable Cardioverter Defibrillators Market, China, Volume (Units), Forecast, 2012-2020
  • Figure 16: Pacemakers Market, China, Volume (Units), Forecast, 2012-2020
  • Figure 17: Cardiac Rhythm Management Market, China, Company Share (%), 2012
  • Figure 18: GlobalData Epidemiology-Based Forecasting Model
  • Figure 19: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 20: Primary Interviews by Participant Type (%)
Back to Top